New Leaf Ventures III L.P. 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 9:04 pm Purchase | 2023-12-31 | 13G | HARPOON THERAPEUTICS INC HARP | New Leaf Ventures III L.P. | 5,643,788 11.000% | 5,018,941![]() (+803.23%) | Filing |
| 2023-03-30 4:43 pm Purchase | 2023-03-23 | 13G | HARPOON THERAPEUTICS INC HARP | New Leaf Ventures III L.P. | 624,847 15.400% | 299,431![]() (+92.01%) | Filing |
| 2023-02-06 4:32 pm Purchase | 2022-12-31 | 13G | HARPOON THERAPEUTICS INC HARP | New Leaf Ventures III L.P. | 325,416 9.800% | 4,230![]() (+1.32%) | Filing |
| 2022-02-11 4:58 pm Purchase | 2021-12-31 | 13G | HARPOON THERAPEUTICS INC HARP | New Leaf Ventures III L.P. | 321,186 9.800% | 28,553![]() (+9.76%) | Filing |
